Dr. George B. Ingrish, MD

Dr. Ingrish practices at Dermatology and Skin Surgery Clinic in Alexandria, Louisiana.

Dr. Ingrish's NPI, 1154344513, was assigned on July 26, 2006. Dr. Ingrish graduated from Tulane University School of Medicine in 1997. Dr. Ingrish holds Louisiana license 021713.

Dr. Ingrish's primary practice is Dermatology and Skin Surgery Clinic, at 201 4th St, Alexandria, LA 71301 in Rapides Parish. The practice phone is (318) 449-8600.

Dr. Ingrish's primary practice is Dermatology and Skin Surgery Clinic in Alexandria, Louisiana. Dr. Ingrish is also affiliated with CHRISTUS St. Frances Cabrini Hospital. The medical group on file is Dermatology & Skin Surgery Clinic. Dmand AI also links Dr. Ingrish to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ingrish practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Ingrish's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ingrish is board certified in dermatology by the American Board of Dermatology. Dr. Ingrish is licensed in Louisiana.

CMS data shows 7,216 Medicare services from Dr. Ingrish across 18 procedure codes in 2024, for 1,551 Medicare patients. Medicare paid $235,505 for them. Every service was in an office.

CMS counts 1,551 Medicare patients who saw Dr. Ingrish in 2024. The largest group is 75 to 84, with 668 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ingrish's median patient age at 71, with 43% women.

In 2024, Dr. Ingrish wrote 2,673 Medicare Part D claims for 747 patients. 86% of them were for generic drugs. CMS names the drug for 2,529 of them, across 48 drugs with 11 or more claims each, at $1,898,751 in total drug cost. In 2023, CMS named 2,654 claims across 46 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ingrish for performance year 2024, reported as part of a group. Dr. Ingrish accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,173 procedures of removal of skin lesions by Dr. Ingrish, more than 98% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 725 general payments to Dr. Ingrish from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. Bristol-Myers Squibb Company paid the most, $9,961.

Dr. Ingrish graduated from Tulane University School of Medicine in 1997.